If you are a HCP and would like to visit the global Hemophilia website, please confirm this by pressing the button below.
This website contains information based on the Summary of Product Characteristics (SPC), as approved by the European Commission on Jivi (damoctog alfa pegol), Kovaltry (octocog alfa) and Kogenate FS (octocog alfa). It is intended to provide information to an international audience. In countries outside the EU, the local Product Information applies.
View our growing library of publication summaries to discover the latest research in hemophilia.
Field study: A publication summary
Comprehensive PK: A publication summary
Discover the Power of Jivi
Latest in Hemophilia
Programs for Your Hemophilia Patients
© 2022 Bayer AG
This website is intended to provide information to an international audience outside the USA and UK
Last updated: June 2022